DXCM - DexCom, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
1,351,200
1,031,600
718,500
573,300
Cost of Revenue
506,200
367,700
226,400
194,900
Gross Profit
845,000
663,900
492,100
378,400
Operating Expenses
Research Development
470,000
417,400
185,400
156,100
Selling General and Administrative
498,800
432,800
349,200
286,200
Total Operating Expenses
968,800
850,200
534,600
442,300
Operating Income or Loss
-123,800
-186,300
-42,500
-63,900
Interest Expense
53,200
22,700
12,800
700
Total Other Income/Expenses Net
-9,100
80,100
3,400
-700
Income Before Tax
-167,000
-126,500
-48,600
-64,900
Income Tax Expense
4,300
600
1,600
700
Income from Continuing Operations
-171,300
-127,100
-50,200
-65,600
Net Income
-171,300
-127,100
-50,200
-65,600
Net Income available to common shareholders
-171,300
-127,100
-50,200
-65,600
Reported EPS
Basic
-
-1.44
-0.58
-0.78
Diluted
-
-1.44
-0.58
-0.78
Weighted average shares outstanding
Basic
-
88,200
86,300
83,600
Diluted
-
88,200
86,300
83,600
EBITDA
-
-103,800
-35,800
-64,200